嘉和生物-B因获采纳2023年受限制股份单位计划归属受限制股份单位而发行68.41万股

Group 1 - The company announced the issuance of 684,100 shares due to the vesting of restricted share units under the 2023 Restricted Share Unit Plan adopted on October 27, 2023 [1] - The company issued 906,600 shares as a result of the exercise of stock options by the CEO under the 2023 Stock Option Plan [1] - Additionally, 284,400 shares were issued due to the exercise of stock options by eligible employees under the post-IPO Stock Option Plan [1]